Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Epidemiologia E Psichiatria Sociale|October 18, 2008
Is early intervention in psychosis effective?Angelo Ricciardi, Victoria McAllister, Paola DazzanNeurotoxicology|August 15, 2019
Cannabidiol (CBD) use in psychiatric disorders: A systematic reviewStefania Bonaccorso, Angelo Ricciardi, Caroline Zangani, et al.Brain, Behavior, & Immunity - Health|February 2, 2021
Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months reportStefania Bonaccorso, Angelo Ricciardi, Sophie Ouabbou, et al.Brain Sciences|December 24, 2025
Managing Dual Diagnosis Patients and the Importance of Assessing Capacity: Data from London Inpatient ServicesIain Hyndman, Angelo Ricciardi, Olesya Ajnakina, et al.Brain Sciences|July 18, 2018
Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management IssuesStefania Bonaccorso, Antonio Metastasio, Angelo Ricciardi, et al.Journal of Psychiatric Research|May 31, 2008
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxineFrancesco Matrisciano, Stefania Bonaccorso, Angelo Ricciardi, et al.Pageof 1